Results 121 to 130 of about 59,240 (301)

How older Canadians access medical cannabis and information about it: A descriptive survey

Cogent Gerontology
To understand older adults’ perceptions regarding access to medical cannabis and information related to it. We employed cross-sectional survey design to recruit Canadians (≥60 years) who consume cannabis for health purpose(s).
Shovana Shrestha, Sherry Dahlke, Jeffrey I. Butler, Rashmi Devkota, Joanna Law, Kathleen F. Hunter, Madeline Toubiana, Maya R. Kalogirou, Melissa Scheuerman, Matthew Pietrosanu   +9 more
doaj   +1 more source

Toronto's drug policy paradox: Harm reduction sites and drug police occurrences in Toronto neighborhoods (1992–2020)

Criminology, EarlyView.
Abstract Discourse around drug policy presents a stark contrast between policing and harm reduction models, sparking debates on the state's regulatory versus protective role. Canada is an ideal case to study drug policy models due to its global recognition as a leader in harm reduction alongside continued reliance on policing of drugs.
Taylor Domingos
wiley   +1 more source

Electroconvulsive Therapy and Time to Psychiatric Readmission in Schizophrenia

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction There is evidence that electroconvulsive therapy (ECT) can augment the effects of antipsychotics in schizophrenia. However, there is limited evidence from Western populations on whether ECT reduces the risk of relapse compared to non‐ECT treatment in schizophrenia.
Linnea Stenmark, Mussie Msghina, Axel Nordenskjöld   +2 more
wiley   +1 more source

Chronic Disease Symptoms Self-Managed by Cannabis During the COVID-19 Pandemic: Results from the COVID-19 Cannabis Health Study [PDF]

The COVID-19 pandemic has impacted billions of people worldwide, particularly those with chronic health conditions, and has been associated with increases in substance use, including cannabis.
Camacho-Rivera, Marlene, Islam, Jessica Y, O'Dell, Nicole, Baral, Amrit, Reid, Marvin, Ortega, Johis, Vidot, Denise C, Diggs, Bria-Necole A   +7 more
core   +1 more source

Cardiometabolic Treatment Gap in Routine Psychiatric Care: A Cross‐Sectional Study of 1553 Patients

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background People with severe mental illness (SMI) have elevated cardiometabolic morbidity and mortality, with similar concerns increasingly reported in other psychiatric conditions including anxiety disorders and ADHD. Somatic conditions are often underdiagnosed and pharmacologically undermanaged in this population.
Vincent Achour, Melanie Faugere, Laurent Boyer, Christophe Lançon, Theo Korchia   +4 more
wiley   +1 more source

Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada

BMC Public Health
Background Benzodiazepines are a class of medications that are being frequently prescribed in Canada but carry significant risk of harm. There has been increasing clinical interest on the potential “sparing effects” of medical cannabis as one strategy to
Cerina Dubois, Heidi Fernandes, Mu Lin, Karen J. B. Martins, Jason R. B. Dyck, Scott W. Klarenbach, Lawrence Richer, Ed Jess, John G. Hanlon, Elaine Hyshka, Dean T. Eurich   +10 more
doaj   +1 more source

Medical cannabis [PDF]

, 2013
The purpose of this Issues Backgrounder is to consider the key legal issues that arise in relation to medical cannabis, in particular the relationship between Commonwealth and State laws.

core  

Daily or near‐daily cannabis and alcohol use by adults in the United States: A comparison across age groups

Addiction, Volume 120, Issue 4, Page 779-782, April 2025.
Abstract Background and aims Patterns of daily or near‐daily (DND) use of alcohol and cannabis among adults in the United States have been changing. The current study measured how these shifts have occurred across developmental periods of adulthood. Design, Setting, and Participants U.S.
Megan E. Patrick
wiley   +1 more source

Factors associated with the use of cannabis for self-medication by adults: data from the French TEMPO cohort study [PDF]

International audienceBackground Medical cannabis, legalized in many countries, remains illegal in France. Despite an experiment in the medical use of cannabis that began in March 2021 in France, little is known about the factors associated with the use ...
Cadwallader, Jean-Sébastien, Wallez, Solène, Melchior, Maria, Rezag Bara, Selma Faten, Andersen, Astrid Juhl, Mary-Krause, Murielle, Kousignian, Isabelle, Hecker, Irwin   +7 more
core   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source